exhibition icon
register now icon
get brochure icon
sponsors icon
add event to diary icon
email this to... icon
contact us icon
Breakthrough
our speakers
Zhaosheng Lin
Head of Biomarkers
Pfizer
 
Nadine Cohen
Head of Pharmacogenomics
Johnson & Johnson
 
Mitchell B. Friedman
Director of Toxicology
Takeda Global R&D
 
Malcolm Mitchell
Medical Director, Clinical Pharmacology
Eli Lilly
 
Dr Russell Weiner
Group Director
Bristol-Myers Squibb
conference details
Conference:
Pre-conference workshop
19 Oct 9am - 5pm
Day 1
20 Oct 8.30am - 5:30pm
Day 2
21 Oct 8.30am - 5:30pm
Post-conference workshop
22 Oct 9am - 5pm
 
Venue: Boston, MA, United States

› Email a friend
› Add this to my calendar

Register online now 
or call +44 (0) 207 608 7055
Contact LIVE
Location
Exploratory Clinical Development World Americas 2010

Breakthrough

When: 20 Oct - 21 Oct
Where: Le Meridien Hotel, Cambridge Massachusetts
Category: Conference

Yilli Prichett, speaking at Exploratory Clinical Development World Americas 2010

Yilli Prichett,
Research Fello, Director Statistics
Abbott Laboratories

Dr. Yili L. Pritchett is a Research Fellow and a Director of Clinical Statistics in Global Pharmaceutical R&D at Abbott Laboratories. She has 15 years of experience in drug development from exploratory phase, confirmatory stage, to NDA filing. She is currently responsible for statistical aspects of drug development in Neuroscience, Pain Care, and Renal Care therapeutic areas. Prior to joining Abbott in 2006, Dr. Pritchett served as a research advisor at Eli Lilly and Company, where she assumed evolving roles in providing statistical leadership for the development of several brands (October 1994 – March 2006). She received her Ph.D. in Statistics from the University of Wisconsin at Madison (1994), and her Bachelor’s and Master degrees in Mathematics from Xiamen University, P.R. China. Dr. Pritchett is currently an active member of PhRMA Adaptive Trial Design Working Group. She has championed the use of adaptive designs in Abbott, and led the effort of designing and implementing a number of clinical trials with different types of adaptive design. Dr. Pritchett authored or o-authored 52 manuscripts or book chapters as well as over 120 presentations made at statistical, drug development, or medical conferences, including several invited presentations on adaptive design in the past two years.
Appearing:
Day One, Wednesday 20 October 2010
2pm

Statistical and Strategic Approaches for Early Phase Clinical Trials

Yilli Prichett,
Research Fello, Director Statistics,
Abbott Laboratories
event sponsors

 

Follow us on Twitter
Twitter logo

› follow us! › tweet this!

Reserve a stand
Reserve an exhibition stand at the Exploratory Clinical Development World Americas exhibition - book early to ensure optimum stand placement!

 
Reserve a stand
 
For details contact
Claire Conway on +44 (0) 207 608 7058


comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX